Dernières publications scientifiques
- Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
Mulleners WM, Kim B, Láinez MJ, Lanteri-Minet M, Aurora SK, Nichols RM, Wang S, Tockhorn-Heidenreich A, Detke HC.Lancet Neurology 2020 Oct;19(10):814-825
PMID: 32949542
- Long-Term Efficacy of Occipital Nerve Stimulation for Medically Intractable Cluster Headache.
Leplus A, Fontaine D, Donnet A, Regis J, Lucas C, Buisset N, Blond S, Raoul S, Guegan-Massardier E, Derrey S, JarrayaB, Dang-Vu B, Bourdain F, Valade D, Roos C, Creach C, Chabardes S, Giraud P, Voirin J, Bloch J, Colnat-Coulbois S, Caire F, Rigoard P, Tran L, Cruzel C, Lantéri-Minet ML , French ONS registry group.Neurosurgery. 2020 Sep 28;nyaa373.
doi: 10.1093/neuros/nyaa373. PMID: 32985662
- Étude de phase III, contrôlée, randomisée, de supériorité de galcanézumab versus placebo, chez les patients atteints de migraine difficile à traiter : résultats de l’étude CONQUER.
Mulleners WM, Kim B, Láinez MJ, Lanteri-Minet M, Aurora SK, Nichols RM, Wang S, Tockhorn-Heidenreich A, Detke HC. Rev Neurol (Paris). 2020 Sep;176S:S100. doi: 10.1016/j.neurol.2020.01.286. PMID: 32906232 French.
- How Should we Use Multicolumn Spinal Cord Stimulation to Optimize Back Pain Spatial Neural Targeting? A Prospective, Multicenter, Randomized, Double-Blind, Controlled Trial (ESTIMET Study).
Rigoard P, Billot M, Ingrand P, Durand-Zaleski I, Roulaud M, Peruzzi P, Dam Hieu P, Voirin J, Raoul S, Page P, Djian MC, Fontaine D, Lantéri-Minet M, Blond S, Buisset N, Cuny E, Cadenne M, Caire F, Ranoux D, Mertens P, Naous H, Simon E, Emery E, Béraud G, Debiais F, Durand G, Serrie A, Diallo B, Bulsei J, Ounajim A, Nivole K, Duranton S, Naiditch N, Monlezun O, Bataille B. Neuromodulation. 2020 Aug 31. doi: 10.1111/ner.13251. Online ahead of print. PMID: 32865344
- TREK-1 channel activation as a new analgesic strategy devoid of opioid adverse effects.
Busserolles J, Soussia IB, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, Eschalier A, Lolignier S. Br J Pharmacol. 2020 Aug 27. doi: 10.1111/bph.15243. Online ahead of print. PMID: 32851651
- DBS for chronic cluster headache: meta-analysis of individual patient data.
Nowacki A, Schober M, Nader L, Saryyeva A, Nguyen TAK, Green AL, Pollo C, Krauss JK, Fontaine D, Aziz TZ. Ann Neurol. 2020 Aug 22. doi: 10.1002/ana.25887. Online ahead of print. PMID: 32827225